Surveillance and vaccine effectiveness of pertussis, the Netherlands, 2012 to 2024, with an unprecedented surge in 2023 and 2024. [PDF]
van Roon A +4 more
europepmc +1 more source
Adenylate cyclase toxin of Bordetella parapertussis disrupts the epithelial barrier granting the bacterial access to the intracellular space of epithelial cells. [PDF]
Gorgojo JP +5 more
europepmc +1 more source
Positivity analysis of <i>Bordetella</i> spp. and SARS-CoV-2 coinfections in clinical samples from Colombia, 2021-2022. [PDF]
Bonilla-Bravo V +11 more
europepmc +1 more source
E I, Shmeleva, M S, Zakharova
openaire +1 more source
Zoonotic <i>Bordetella bronchiseptica</i> infection at the swine-human interface: unveiling the evolutionary path from an animal to a human pathogen. [PDF]
Liu J +13 more
europepmc +1 more source
One Sample, Many Insights: The Epidemiological and Public Health Value of Multiplex PCR Respiratory Panels Following the End of the COVID-19 Pandemic. [PDF]
Kaliterna V +5 more
europepmc +1 more source
Analysis of Macrolide Resistance in Bordetella pertussis Isolated from Japanese Children in 2025 Using Test Kit and Sequence Method. [PDF]
Oishi T, Nakano T.
europepmc +1 more source
Architecture and regulatory functions of c-di-GMP signaling in classical Bordetella species. [PDF]
Vondrova D +6 more
europepmc +1 more source
Multicenter clinical performance and comparative evaluation of the LIAISON PLEX Respiratory <i>Flex</i> Assay for syndromic detection of viral and bacterial pathogens in nasopharyngeal swabs. [PDF]
Gonzalez K +6 more
europepmc +1 more source
Determining the <i>Bordetella</i> LPS structural features that influence TLR4 downstream signaling. [PDF]
Manivannan K +2 more
europepmc +1 more source

